Hillhouse Capital has introduced an incubation strategy that is intended to support China-based start-ups from incubation through the seed stage.
The programme, called Aseed+, will focus on manufacturing, new energy, new materials, biotech, and carbon neutrality. Cheque sizes will be in the USD 2m-USD 3m range, although it is unclear what the upper...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.